Sign in
4

Changes in Ownership

Evolent Health, Inc. Filed Acc 0000950157-16-002176

Chief Financial Officer sold 21,205 shares at $21.54 ($456,756)

  • Chief Financial Officer acquired 21,205 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McGrane Nicholas · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-14 Exercise or conversion : show line 1 in the form +21,205 $3.84 $81,427 136,495 D
2016-09-14 Sale : show line 2 in the form −21,205 $21.54 $456,756 115,290 D
Open-market sales · 21,205 sh · avg $21.54 · $456,756

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-09-14 Exercise or conversion : show line 3 in the form Class A Common Stock Option (right to buy) −21,205 $3.84 2024-10-22 21,205 278,795 D
Loading xslF345X03/form4.xml…